Skip to content

Compare the effect of TDCS with TENS on osteoarthritis of the knee

Comparison of the Therapeutic Effect of Transcutaneous Electrical Nerve Stimulation (TENS) with Transcranial Direct Current Stimulation (TDCS) in Patients with Knee Osteoarthritis

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT20190804044431N1
Enrollment
40
Registered
2019-10-18
Start date
2019-10-12
Completion date
Unknown
Last updated
2019-11-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Knee Osteoarthritis. Bilateral primary osteoarthritis of knee

Interventions

Intervention 1: Intervention group: In this group, patients receive 6 sessions of TDCS treatment ( 2 mA intensity for 20 minutes and two 35cm2 electrodes that anode pole placed at the motor area and c

Sponsors

Iran University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
50 Years to No maximum

Inclusion criteria

Inclusion criteria: Knee Osteoarthritis based on American College of Rheumatology criteria in Grades 1, 2 and 3 according to Lowrence - Kellergan criteria People with idiopathic osteoarthritis and VAS = 4 based on ACR criteria No Radicular Low Back Pain The absence of any neurological and musculosceletal diseases that affect lower extremity function No diabetes No major depression disease No Drug abuse Knee pain for at least six months Over 50 years old No any acute or chronic infection No pregnancy or no pregnancy decision No inflammatory arthritis or secondary osteoarthritis No history of knee surgery No underlying disease of seizure No unstable conditions No metal objects near the electrode Patients not using Synchronous Pacemakers

Exclusion criteria

Exclusion criteria: The willingness of patients to exit from the study at any stage of the study

Design outcomes

Primary

MeasureTime frame
The severity of knee pain. Timepoint: The severity of knee pain before, immediately, 1 and 3 months after study initiation. Method of measurement: Visual Analogue Scale.;The severity of symptoms and functional limitations. Timepoint: The severity of symptoms and functional limitations before, immediately, 1 and 3 months after study initiation. Method of measurement: By using WOMAC questionnaire.

Secondary

MeasureTime frame
Side effects. Timepoint: 4 and 12 weeks later. Method of measurement: Physical Examination.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMalihe Karimi

Iran University of Medical Sciences

karimi_malihe@yahoo.com+98 21 8214 1229

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026